Eur Rev Med Pharmacol Sci 2021; 25 (6): 2462-2462
DOI: 10.26355/eurrev_202103_25402

LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p

X. Shi, X. You, W.-C. Zeng, Y.-J. Deng, H.-L. Hong, O.-X. Huang, M.-F. Wang

Department of Medical Oncology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.


Since this paper presents several inaccuracies and mistakes, the article “LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p, by X. Shi, X. You, W.-C. Zeng, Y.-J. Deng, H.-L. Hong, O.-X. Huang, M.-F. Wang, published in Eur Rev Med Pharmacol Sci 2019; 23 (24): 10761-10768–DOI: 10.26355/eurrev_201912_19778–PMID: 31858543” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

 

https://www.staging.europeanreview.org/article/19778

Free PDF Download

To cite this article

X. Shi, X. You, W.-C. Zeng, Y.-J. Deng, H.-L. Hong, O.-X. Huang, M.-F. Wang
LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 6
Pages: 2462-2462
DOI: 10.26355/eurrev_202103_25402